Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma.


Journal

Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395

Informations de publication

Date de publication:
2021
Historique:
received: 20 03 2021
accepted: 06 08 2021
entrez: 14 10 2021
pubmed: 15 10 2021
medline: 8 2 2022
Statut: epublish

Résumé

Tryptophan (Trp)-catabolic enzymes (TCEs) produce metabolites that activate the aryl hydrocarbon receptor (AHR) and promote tumor progression and immunosuppression in glioblastoma. As therapies targeting TCEs or AHR become available, a better understanding of Trp metabolism is required.

Identifiants

pubmed: 34646367
doi: 10.7150/thno.60679
pii: thnov11p9217
pmc: PMC8490504
doi:

Substances chimiques

Receptors, Aryl Hydrocarbon 0
Tryptophan 8DUH1N11BX

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9217-9233

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: A.S., S.T. and C.A.O. are listed as inventors on WO/2020/201825, C.A.O., M.P. and W.W. are listed as inventors on WO/2013/034685, S.K., M.P., P.S.K., I.P. and C.A.O. are listed as inventors on WO/2017/072368. S.K., V.F., S.J., K.K., S.Se., P.S.K. and I.P. have been employed or are employed by Proteome Sciences. W.W. receives trial funding from Apogenix, Boehringer Ingelheim, Pfizer and Roche to the institution. He serves on advisory boards for Agios, Bayer, MSD, Novartis, Roche with compensation paid to the institution. The authors not listed above declare that they have no competing interests.

Références

Bioanalysis. 2016 Sep;8(18):1903-17
pubmed: 27524289
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Ann Appl Stat. 2016 Jun;10(2):946-963
pubmed: 28367255
Cancer Immunol Res. 2020 Jan;8(1):32-45
pubmed: 31806638
Invest New Drugs. 2020 Dec;38(6):1784-1795
pubmed: 32436060
Nat Rev Clin Oncol. 2018 Jul;15(7):422-442
pubmed: 29643471
Front Immunol. 2020 May 14;11:657
pubmed: 32477324
Anal Chem. 2014 Apr 1;86(7):3585-93
pubmed: 24611633
Front Immunol. 2019 Dec 04;10:2762
pubmed: 31866995
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Bioinformatics. 2006 Dec 15;22(24):3067-74
pubmed: 17032683
Cancers (Basel). 2020 Jul 28;12(8):
pubmed: 32731514
BMC Cancer. 2014 Jul 09;14:498
pubmed: 25011475
Nat Genet. 2016 Aug;48(8):838-47
pubmed: 27322546
Cancer Cell. 2018 Mar 12;33(3):480-494.e7
pubmed: 29533786
Br J Cancer. 2020 Jan;122(1):30-44
pubmed: 31819194
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Nature. 2011 Oct 05;478(7368):197-203
pubmed: 21976023
Cancer Cell. 2017 Jul 10;32(1):42-56.e6
pubmed: 28697342
Front Immunol. 2020 Apr 24;11:737
pubmed: 32391020
J Neuropathol Exp Neurol. 2015 May;74(5):390-400
pubmed: 25853692
Clin Cancer Res. 2018 Aug 1;24(15):3632-3643
pubmed: 29691296
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96
pubmed: 33123732
J Neurosurg. 2009 Aug;111(2):230-7
pubmed: 19199463
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Neurooncol. 2021 Jan;151(1):41-53
pubmed: 32253714
Cancer Immunol Res. 2020 Jan;8(1):19-31
pubmed: 31806639
Anal Bioanal Chem. 2013 Nov;405(29):9467-76
pubmed: 24121470
PLoS One. 2014 Nov 21;9(11):e112945
pubmed: 25415278
BMC Bioinformatics. 2006 Mar 09;7:123
pubmed: 16526949
Nat Rev Clin Oncol. 2021 Mar;18(3):170-186
pubmed: 33293629
Cell Rep. 2017 Oct 31;21(5):1399-1410
pubmed: 29091775
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Cancers (Basel). 2020 Oct 10;12(10):
pubmed: 33050543
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4009-14
pubmed: 23412337
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
Nat Methods. 2020 Feb;17(2):137-145
pubmed: 31792435
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Oncogenesis. 2020 Nov 19;9(11):102
pubmed: 33214553
Signal Transduct Target Ther. 2020 Feb 21;5(1):10
pubmed: 32296044
Stem Cells. 2016 Aug;34(8):2026-39
pubmed: 27145382
Cells. 2021 Apr 14;10(4):
pubmed: 33919732
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Cell. 2020 Jun 25;181(7):1643-1660.e17
pubmed: 32470396
Cancer Immunol Immunother. 2019 Jul;68(7):1107-1120
pubmed: 31119318
Semin Cancer Biol. 2020 Aug;64:13-18
pubmed: 31128300
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cell. 2015 Jul 2;162(1):184-97
pubmed: 26095251
JCI Insight. 2016;1(2):
pubmed: 26973881
BMC Bioinformatics. 2017 Jun 24;18(1):314
pubmed: 28646877
Cancer Res. 2019 Nov 1;79(21):5550-5562
pubmed: 31431462
Cell. 2020 Sep 3;182(5):1252-1270.e34
pubmed: 32818467
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
PLoS One. 2012;7(8):e43339
pubmed: 22937035
Cells. 2020 Dec 24;10(1):
pubmed: 33374253
J Neural Transm Suppl. 1979;(15):43-54
pubmed: 385809
Cell. 2019 Aug 8;178(4):835-849.e21
pubmed: 31327527
Nat Commun. 2019 Sep 25;10(1):4346
pubmed: 31554815
J Proteome Res. 2021 May 7;20(5):2964-2972
pubmed: 33900084
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2497-502
pubmed: 22308364
Cancer Discov. 2020 Aug;10(8):1210-1225
pubmed: 32300059
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Nat Rev Drug Discov. 2019 May;18(5):379-401
pubmed: 30760888
Cancer Cell. 2021 Jun 14;39(6):779-792.e11
pubmed: 34087162
Genome Biol. 2019 Mar 19;20(1):59
pubmed: 30890159
Ther Adv Neurol Disord. 2018 Jul 25;11:1756286418790452
pubmed: 30083233
Mass Spectrom Rev. 2020 May;39(3):229-244
pubmed: 28691345
Oncoimmunology. 2013 Mar 1;2(3):e23428
pubmed: 23802083
Nat Neurosci. 2019 May;22(5):729-740
pubmed: 30962630
Nat Neurosci. 2016 Jan;19(1):20-7
pubmed: 26713745
J Neurooncol. 2018 Sep;139(2):239-249
pubmed: 29667084
J Sep Sci. 2017 Aug;40(15):3020-3045
pubmed: 28590049
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
J Biol Chem. 2013 Nov 29;288(48):34555-66
pubmed: 24129579
Sci Rep. 2020 Jun 2;10(1):8979
pubmed: 32488114
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
J Biol Chem. 2019 Jul 19;294(29):11342-11353
pubmed: 31171720
Anal Chem. 2003 Apr 15;75(8):1895-904
pubmed: 12713048
Genome Biol. 2017 Dec 20;18(1):234
pubmed: 29262845
Nat Rev Immunol. 2019 Mar;19(3):184-197
pubmed: 30718831
Immunity. 2018 Jan 16;48(1):19-33
pubmed: 29343438
Curr Opin Immunol. 2021 Jun;70:57-66
pubmed: 33813026
J Clin Neurosci. 2015 Dec;22(12):1964-8
pubmed: 26279502
Nat Med. 2003 Oct;9(10):1269-74
pubmed: 14502282
Lancet Oncol. 2019 May;20(5):728-740
pubmed: 30952559
Nat Commun. 2019 Oct 25;10(1):4899
pubmed: 31653878
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923

Auteurs

Verena Panitz (V)

DKTK Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Department of Neurology and National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Saša Končarević (S)

Proteome Sciences R&D GmbH & Co. KG, Altenhöferallee 3, 60438 Frankfurt/Main, Germany.

Ahmed Sadik (A)

DKTK Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Faculty of Bioscience, Heidelberg University, 69120 Heidelberg, Germany.

Dennis Friedel (D)

DKTK Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Faculty of Bioscience, Heidelberg University, 69120 Heidelberg, Germany.

Tobias Bausbacher (T)

Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, 68163 Mannheim, Germany.

Saskia Trump (S)

Molecular Epidemiology Unit, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.

Vadim Farztdinov (V)

Proteome Sciences R&D GmbH & Co. KG, Altenhöferallee 3, 60438 Frankfurt/Main, Germany.

Sandra Schulz (S)

Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, 68163 Mannheim, Germany.

Philipp Sievers (P)

Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Stefan Schmidt (S)

Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, 68163 Mannheim, Germany.

Ina Jürgenson (I)

DKTK Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Department of Neurology and National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Stephan Jung (S)

Proteome Sciences R&D GmbH & Co. KG, Altenhöferallee 3, 60438 Frankfurt/Main, Germany.

Karsten Kuhn (K)

Proteome Sciences R&D GmbH & Co. KG, Altenhöferallee 3, 60438 Frankfurt/Main, Germany.

Irada Pflüger (I)

Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Suraj Sharma (S)

Department of Arctic and Marine Biology, UiT, The Arctic University of Norway, 9037 Tromsø, Norway.

Antje Wick (A)

Department of Neurology and National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Pauline Pfänder (P)

DKTK Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Faculty of Bioscience, Heidelberg University, 69120 Heidelberg, Germany.

Stefan Selzer (S)

Proteome Sciences R&D GmbH & Co. KG, Altenhöferallee 3, 60438 Frankfurt/Main, Germany.

Philipp Vollmuth (P)

Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Felix Sahm (F)

Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Andreas von Deimling (A)

Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Ines Heiland (I)

Department of Arctic and Marine Biology, UiT, The Arctic University of Norway, 9037 Tromsø, Norway.

Carsten Hopf (C)

Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, 68163 Mannheim, Germany.

Peter Schulz-Knappe (P)

Proteome Sciences R&D GmbH & Co. KG, Altenhöferallee 3, 60438 Frankfurt/Main, Germany.

Ian Pike (I)

Proteome Sciences plc, 5 Dashwood Lang Road, Bourne Business Park, Addlestone, Surrey KT15 2HJ, United Kingdom.

Michael Platten (M)

Department of Neurology, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Wolfgang Wick (W)

Department of Neurology and National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Christiane A Opitz (CA)

DKTK Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Department of Neurology and National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH